
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 4.120 | 4.120 | 0.000 |
Shares | 95.880 | 95.880 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 28.523 | 35.009 |
Price to Book | 2.770 | 3.883 |
Price to Sales | 3.830 | 5.038 |
Price to Cash Flow | 14.285 | 23.817 |
Dividend Yield | 0.919 | 0.883 |
5 Years Earnings Growth | 10.940 | 13.241 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 97.350 | 96.854 |
Basic Materials | 1.500 | 4.452 |
Financial Services | 1.150 | 3.177 |
Number of long holdings: 40
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Sun Pharma | INE044A01036 | 11.71 | 1,655.50 | +0.05% | |
Dr Reddy’s Laboratories | INE089A01031 | 9.47 | 1,248.00 | -0.05% | |
Divi's Labs | INE361B01024 | 9.23 | 6,116.00 | +4.97% | |
Cipla | INE059A01026 | 7.39 | 1,513.00 | -0.01% | |
Aurobindo Pharma | INE406A01037 | 6.53 | 1,091.50 | -0.46% | |
Lupin | INE326A01037 | 5.44 | 1,926.90 | -0.54% | |
Alkem Laboratories Ltd | INE540L01014 | 4.00 | 5,500.00 | +0.11% | |
Mankind Pharma | INE634S01028 | 3.50 | 2,482.35 | +1.24% | |
Biocon | INE376G01013 | 3.21 | 348.95 | +0.35% | |
Gland | INE068V01023 | 2.88 | 1,935.50 | -0.21% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
ICICI Focused Bluechip Equity RetGr | 718.4B | 4.90 | 17.29 | 14.36 | ||
ICICI Focused Bluechip Eq RetailDiv | 718.4B | 4.13 | 16.44 | 13.55 | ||
ICICI Prud Focused Bluechip Div | 718.4B | 5.05 | 17.70 | 14.84 | ||
ICICI Prud Focused Bluechip Gr | 718.4B | 5.28 | 17.96 | 15.20 | ||
ICICI Balanced Adv Dir Div | 657.11B | 7.51 | 12.94 | 11.61 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review